FCER2 antibody
Quick Overview for FCER2 antibody (ABIN135164)
Target
See all FCER2 AntibodiesReactivity
Host
Clonality
Conjugate
Application
Clone
-
-
Specificity
- Mouse CD23, Mr 45-49 kDa
-
Characteristics
- Rat Anti-Mouse CD23-UNLB
-
Purification
- Purified
-
Immunogen
- FcR isolated from B cell lymphoma cell line M12.4.5
-
Isotype
- IgG2a
-
-
-
-
Application Notes
-
- Applications: FC - Quality tested , IHC-FS - Reported in literature , ELISA - Reported in literature
- Working Dilutions: Flow Cytometry Purified (UNLB) antibody 1 g/106 cells FITC and BIOT conjugates 1 g/106 cells PE, APC, and PE/CY7 conjugates 0.1 g/106 cells For flow cytometry, the suggested use of these reagents is in a final volume of 100 L
-
Comment
-
cell sorting
-
Sample Volume
- 1 mL
-
Restrictions
- For Research Use only
-
-
-
Concentration
- 0.5 mg/mL
-
Buffer
- 0.5 mg of purified immunoglobulin in 1.0 mL of borate buffered saline, pH 8.2. No preservatives or amine-containing buffer salts added
-
Preservative
- Without preservative
-
Handling Advice
- Each reagent is stable for the period shown on the bottle label if stored as directed.
-
Storage
- 4 °C
-
Storage Comment
- Store at 2-8°C
-
-
- FCER2 (Fc Fragment of IgE, Low Affinity II, Receptor For (CD23) (FCER2))
-
Alternative Name
- CD23
-
Background
- The CD23 antigen is the low affinity IgE Fc receptor, which is a 49 kDa protein with 38 and 28 kDa fragments. It is expressed on most mature, conventional B cells (but not on peritoneal CD5+ B cells), and can also be found on the surface of T cells, macrophages and platelets. It is distinct from the high affinity IgE receptors found on basophils and mast cells, which mediate allergic reactions. The low affinity receptors are thought to play a role in isotype specific immunoregulation. The regulation of CD23 surface expression appears to be integral with the complex IgE system, which involves interactions of cells, cytokines, antibodies and regulatory factors. CD23 has been described as a membrane bound cytokine, in that the soluble cleavage products of CD23 are themselves able to act as cytokines in vitro.
-
Pathways
- Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process
Target
-